Eikon Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 5.31 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 287.62M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006, a clinical candidate and next-generation androgen receptor antagonist with activity against multiple clinically emergent variants of androgen receptor. The company was incorporated in 2019 and is based in Millbrae, California.
Details
| Name | Eikon Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 384 |
| Founded | 2019 |
| Ipo Date | 2026-02-05 |
| Ceo | Roger Perlmutter |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 18.00 |
| Isin | US2825641036 |
| Cusip | 282564103 |
| Cik | 1861123 |
| Sic | 2836 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Roger M. Perlmutter M.D., Ph.D. | Chairman, President and Chief Executive Officer |
| Michael A. Klobuchar | Chief Operating Officer |
| Dr. Roy D. Baynes FACP, M.D., Ph.D. | Executive Vice President and Chief Medical Officer |
| Dr. Robert Tjian Ph.D. | Co-Founder and Member of Scientific Advisory Board |
| Dr. Eric Betzig Ph.D. | Co-Founder and Member of Scientific Advisory Board |
| Dr. Alfred Lloyd Bowie Jr., Ph.D. | Treasurer and Chief Financial Officer |
| Russ Berman | Chief Technology Officer |
| Dr. Ching-Pin Chang M.D., Ph.D. | Executive Vice President and Chief Scientific Officer |
| Benjamin Bruno Thorner | Secretary, General Counsel and Chief Business Officer |
| Barbara Howes M.B.A. | Chief People Officer |
Contact
| Address | 230 Harriet Tubman Way, Millbrae, California 94030, United States |
| Phone | 341 777 0566 |
| Website | https://eikontx.com |